Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Lai, Shiue-Wei; Bamodu, Oluwaseun Adebayo; Tsai, Wen-Chiuan; Chang, Yi-Ming; Lee, Wei-Hwa; Yeh, Chi-Tai; Chao, Tsu-Yi

doi:10.1007/s10585-018-9949-z

Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Correction
Published: 04 January 2019

Volume 36, page 67, (2019)
Cite this article

Download PDF

Clinical & Experimental Metastasis Aims and scope Submit manuscript

Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Download PDF

Shiue-Wei Lai^1,2,3,
Oluwaseun Adebayo Bamodu^4,5,
Wen-Chiuan Tsai^6,7,
Yi-Ming Chang^6,7,
Wei-Hwa Lee^5,8,
Chi-Tai Yeh ORCID: orcid.org/0000-0001-5189-9755^9,10,11 &
…
Tsu-Yi Chao^12,13,14

1034 Accesses
2 Citations
Explore all metrics

The Original Article was published on 09 July 2018

Correction to: Clinical & Experimental Metastasis (2018) 35:663–677 https://doi.org/10.1007/s10585-018-9919-5

In the original publication, the affiliations of authors were published incorrectly. The corrected affiliations are given in this Correction.

Author information

Authors and Affiliations

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Shiue-Wei Lai
Division of Hematology-Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Shiue-Wei Lai
Department of Internal Medicine, Tri-Service General Hospital Penghu Branch, Penghu, Taiwan
Shiue-Wei Lai
Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan
Oluwaseun Adebayo Bamodu
Department of Medical Research and Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan
Oluwaseun Adebayo Bamodu & Wei-Hwa Lee
Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Wen-Chiuan Tsai & Yi-Ming Chang
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
Wen-Chiuan Tsai & Yi-Ming Chang
Department of Pathology, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan
Wei-Hwa Lee
Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan
Chi-Tai Yeh
Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan
Chi-Tai Yeh
Department of Medical Research and Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan
Chi-Tai Yeh
Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan
Tsu-Yi Chao
Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan
Tsu-Yi Chao
Department of Medical Research and Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan
Tsu-Yi Chao

Authors

Shiue-Wei Lai
View author publications
You can also search for this author in PubMed Google Scholar
Oluwaseun Adebayo Bamodu
View author publications
You can also search for this author in PubMed Google Scholar
Wen-Chiuan Tsai
View author publications
You can also search for this author in PubMed Google Scholar
Yi-Ming Chang
View author publications
You can also search for this author in PubMed Google Scholar
Wei-Hwa Lee
View author publications
You can also search for this author in PubMed Google Scholar
Chi-Tai Yeh
View author publications
You can also search for this author in PubMed Google Scholar
Tsu-Yi Chao
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Chi-Tai Yeh or Tsu-Yi Chao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lai, SW., Bamodu, O.A., Tsai, WC. et al. Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity. Clin Exp Metastasis 36, 67 (2019). https://doi.org/10.1007/s10585-018-9949-z

Download citation

Published: 04 January 2019
Issue Date: 15 February 2019
DOI: https://doi.org/10.1007/s10585-018-9949-z

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Clinical & Experimental Metastasis (2018) 35:663–677 https://doi.org/10.1007/s10585-018-9919-5

Author information

Authors and Affiliations

Corresponding authors

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation